NCT00763204View on ClinicalTrials.gov

A Phase I Study to Assess Novel Cream in a Psoriasis Plaque Test

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

March 7, 2008

Study Completion Date

March 7, 2008

Conditions

Psoriasis

Interventions

DRUG

AN2728 Cream, 2%

DRUG

AN2728 Cream, 1%

DRUG

AN2728 Cream, 0.3%

DRUG

AN2728 Cream Vehicle

DRUG

Betnesol®-V Creme, 0.1%

Trial Locations (1)

10117

Bioskin GmbH, Hamburg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY